Its impact on disease progression appears to be gene-dosage-dependent, as complete deletion of HK2 exacerbates inflammation and mitochondrial dysfunction, whereas partial reduction (haploinsufficiency) alleviates AD pathogenesis in AD model mice [50]. The gene discussed is HK2; the disease is Alzheimer disease.